Analysts predict Inovio Pharmaceuticals Inc (INO) stock to reach $8 in the next 12 months
At the time of writing, Inovio Pharmaceuticals Inc [INO] stock is trading at $2.20, up 5.77%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The INO shares have gain 15.79% over the last week, with a monthly amount glided 12.24%, and seem to […]
Analyzing Inovio Pharmaceuticals Inc (INO)’s Gross, Operating, Pretax, and Net Margins
Inovio Pharmaceuticals Inc [INO] stock is trading at $1.98, down -5.26%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The INO shares have gain 8.79% over the last week, with a monthly amount drifted -52.17%, and not seem to be holding up well over […]
Inovio Pharmaceuticals Inc (INO) stock expected to rise by 308.16%: What’s driving the optimism?
A share price of Inovio Pharmaceuticals Inc [INO] is currently trading at $1.96, up 7.69%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The INO shares have gain 5.38% over the last week, with a monthly amount drifted -53.33%, and not seem to […]
Analyzing Inovio Pharmaceuticals Inc (INO)’s Gross, Operating, Pretax, and Net Margins
Inovio Pharmaceuticals Inc [INO] stock is trading at $1.86, up 1.64%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The INO shares have gain 4.49% over the last week, with a monthly amount drifted -54.96%, and not seem to be holding up well over […]
Inovio [NASDAQ: INO] Wins Approval to Conduct Phase 3 Trial of its COVID-19 Vaccine
Inovio Pharmaceuticals, Inc. [NASDAQ: INO] share has skyrocketed 2.16% during the pre-market trading session after the firm disclosed that it has won the approval to carry out a clinical study in that country as part of the Phase III segment of INOVIO’s global Phase 2/3 trial, INNOVATE, for its DNA vaccine candidate for COVID-19, INO-4800. […]
